PHARMACOGENOMICS IN CANCER THERAPY: PERSONALIZED MEDICINE FOR BETTER OUTCOMES
Anannya Mathew*, Kummari Ganesh, Bhargav Raj M. S., Dhanya P. V., Immadi Madhan Mohan, Habeeb Rahman Khan, Mohammadakil Shaikh, Shaikh Mohmed Adnan Mohmed Javid, Divy H. Bhimani, Morziul Haque and Santosh S.
ABSTRACT
Pharmacogenomics, the study of how genetic differences impact drug reactions, is essential to cancer therapy because it makes customized treatment plans possible. The integration of pharmacogenomics in cancer care is examined in this review, which emphasizes how genetic profiling enables personalized therapy that improve efficacy and minimize side effects. Based on the patient's genetic composition, personalized medicine enables targeted cancer treatments that improve therapeutic outcomes and increase survival rates. Discussed are significant developments in pharmacogenomic applications for cancer treatment, including the utilization of immunotherapies and targeted treatments. Furthermore, the difficulties and potential paths for pharmacogenomic-based cancer therapy implementation in clinical settings are analyzed. In general, this review emphasizes how crucial it is to use pharmacogenomics in cancer treatment in order to provide tailored, precision medicine for the best possible outcomes for patients.
[Full Text Article] [Download Certificate]